Tafluprost

Chemical formula: C₂₅H₃₄F₂O₅  Molecular mass: 452.531 g/mol  PubChem compound: 9868491

Therapeutic indications

Tafluprost is indicated for:

Open angle glaucoma, ocular hypertension

Population group: only adults (18 years old or older)

Reduction of elevated intraocular pressure in open angle glaucoma and ocular hypertension.

As monotherapy in patients:

  • who would benefit from preservative free eye drops
  • insufficiently responsive to first line therapy
  • intolerant or contra-indicated to first line therapy

As adjunctive therapy to beta-blockers.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Tafluprost is contraindicated in the following cases:

Lactation

Lactation

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2019: SAFLUTAN Eye drops, solution
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈